Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: PON1 M/L55 mutation protects high-risk patients against coronary artery disease
Author: Oliveira, SA
Mansur, AP
Ribeiro, CC
Ramires, JAF
Annichino-Bizzacchi, JM
Abstract: The paraoxonase (PON) gene family contains at least three members: PON1, PON2, and PON3. The enzyme PON1 has been implicated in the pathogenesis of atherosclerosis. Recently, an association between PON2 and quantitative metabolic phenotypes, such as plasma lipoproteins, plasma glucose, and coronary artery disease (CAD), has been reported. We analyzed two common polymorphisms in PON1 (i.e., M/L55 and R/Q 192 Mutations) and PON2 (i.e., G/A148 and C/S311 mutations) in 352 high-risk patients with angiographically defined CAD. These results were compared to those in 380 age- and sex-matched control subjects at high risk for CAD. Polymerase chain reaction with specific primers followed by Hsp92, Alw1, DdeI and Fnu4HI restriction digestion were employed to identify the PON1 M/L55 and R/Q192 and the PON2 G/A148 and C/S311 genotypes, respectively. Univariate analysis showed a higher prevalence of the MM genotype (12% vs. 5%; p = 0.004) for the PON1 M/L55 polymorphism and the GG genotype (21% vs. 15%; p = 0.047) PON2 G/A148 polymorphism in the control subjects. The PON1 M/L55 mutation (MM genotype) was associated with lower triglyceride levels and the PON2 G/A148 mutation (GG genotype), with higher total and low-density lipoprotein (LDL)-cholesterol levels. No mutation was associated with the number of major coronary artery vessels with a >50% reduction in lumen diameter. Multiple regression analysis disclosed smoking, a family history of CAD, high-density lipoprotein (HDL)-cholesterol and the PON1 M/L55 mutation [OR = 0.59 (CI95%: 0.42-0.82); p = 0.002] as independent markers for CAD. In contrast to traditional coronary risk factors, the PON1 M/L mutation can be considered predictive of protection against CAD. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
Subject: paraoxonase
coronary artery disease
Country: Irlanda
Editor: Elsevier Sci Ireland Ltd
Citation: International Journal Of Cardiology. Elsevier Sci Ireland Ltd, v. 94, n. 1, n. 73, n. 77, 2004.
Rights: fechado
Identifier DOI: 10.1016/j.ijcard.2003.05.011
Date Issue: 2004
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000220258900012.pdf102.75 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.